Administration of recombinant G-CSF to neonates with early-onset bacterial sepsis and neutropenia will be studied to determine effects upon the duration of neutropenia, and improvement of neutrophil chemotaxis and superoxide production in relation to length of illness.
Showing the most recent 10 out of 535 publications